| pubmed-article:220353 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:220353 | lifeskim:mentions | umls-concept:C0024400 | lld:lifeskim |
| pubmed-article:220353 | lifeskim:mentions | umls-concept:C0008395 | lld:lifeskim |
| pubmed-article:220353 | lifeskim:mentions | umls-concept:C0598784 | lld:lifeskim |
| pubmed-article:220353 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:220353 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:220353 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:220353 | pubmed:dateCreated | 1979-7-16 | lld:pubmed |
| pubmed-article:220353 | pubmed:abstractText | Hypercholesterolemia was induced in adult male rhesus monkeys with a high-fat diet containing an elevated cholesterol level (0.5%). Plasma lipoproteins were chromatographically separated into four size populations (regions) that were subdivided by density until fractions with single electrophoretic mobilities were obtained. The region III lipoproteins (LDL) contained 80% of plasma cholesterol and were present in the highest concentration of all fractions. Their molecular weight was increased over that of controls so that each particle averaged 1.8 times the number of cholesteryl ester molecules as did control LDL. Region II lipoproteins, a heterogeneous group, were present in next highest concentration. Most were cholesteryl ester-rich, beta-migrating lipoproteins that overlapped the VLDL and LDL density ranges; apoB was the predominant apoprotein. One region II subfraction had pre beta 2 migration and the density range. 1.050 less than d less than 1.10. Another subfraction, cholesteryl ester-rich VLDL including only about 1% of plasma cholesterol, had pre beta 1 migration and apoB and apoC as the predominant apoproteins with no apoprotein E. Region I lipoproteins were larger sized, slow beta-migrating cholesteryl ester-rich VLDL that included 5% of plasma cholesterol. ApoB and apoE were the predominant apoproteins. Region IV lipoproteins (HDL) contained 4% of the plasma cholesterol; their concentration was decreased to about 1/3 of the control level. Atherogenic features of the diet-induced dyslipoproteinemia included the increased plasma concentrations and cholesteryl ester contents of the region I, II, and III lipoproteins in addition to the decreased HDL concentration. | lld:pubmed |
| pubmed-article:220353 | pubmed:language | eng | lld:pubmed |
| pubmed-article:220353 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:220353 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:220353 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:220353 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:220353 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:220353 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:220353 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:220353 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:220353 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:220353 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:220353 | pubmed:issn | 0022-2275 | lld:pubmed |
| pubmed-article:220353 | pubmed:author | pubmed-author:ShahRR | lld:pubmed |
| pubmed-article:220353 | pubmed:author | pubmed-author:RudelL LLL | lld:pubmed |
| pubmed-article:220353 | pubmed:author | pubmed-author:GreeneD GDG | lld:pubmed |
| pubmed-article:220353 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:220353 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:220353 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:220353 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:220353 | pubmed:pagination | 55-65 | lld:pubmed |
| pubmed-article:220353 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:220353 | pubmed:meshHeading | pubmed-meshheading:220353-A... | lld:pubmed |
| pubmed-article:220353 | pubmed:meshHeading | pubmed-meshheading:220353-C... | lld:pubmed |
| pubmed-article:220353 | pubmed:meshHeading | pubmed-meshheading:220353-H... | lld:pubmed |
| pubmed-article:220353 | pubmed:meshHeading | pubmed-meshheading:220353-L... | lld:pubmed |
| pubmed-article:220353 | pubmed:meshHeading | pubmed-meshheading:220353-M... | lld:pubmed |
| pubmed-article:220353 | pubmed:meshHeading | pubmed-meshheading:220353-H... | lld:pubmed |
| pubmed-article:220353 | pubmed:meshHeading | pubmed-meshheading:220353-C... | lld:pubmed |
| pubmed-article:220353 | pubmed:meshHeading | pubmed-meshheading:220353-M... | lld:pubmed |
| pubmed-article:220353 | pubmed:meshHeading | pubmed-meshheading:220353-D... | lld:pubmed |
| pubmed-article:220353 | pubmed:meshHeading | pubmed-meshheading:220353-L... | lld:pubmed |
| pubmed-article:220353 | pubmed:meshHeading | pubmed-meshheading:220353-L... | lld:pubmed |
| pubmed-article:220353 | pubmed:meshHeading | pubmed-meshheading:220353-L... | lld:pubmed |
| pubmed-article:220353 | pubmed:year | 1979 | lld:pubmed |
| pubmed-article:220353 | pubmed:articleTitle | Study of the atherogenic dyslipoproteinemia induced by dietary cholesterol in rhesus monekys (Macaca mulatta). | lld:pubmed |
| pubmed-article:220353 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:220353 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:220353 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:220353 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:220353 | lld:pubmed |
